Qun Wang

Fudan University - Department of Thoracic Surgery

China

SCHOLARLY PAPERS

2

DOWNLOADS

1,032

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Survival Benefit of Surgery Versus Radiotherapy Alone to Patients with Stage IA Lung Adenocarcinoma: A Propensity Score-Matched Analysis

Number of pages: 23 Posted: 09 Feb 2023
Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery and Fudan University - Department of Thoracic Surgery
Downloads 991 (50,699)

Abstract:

Loading...

Lung adenocarcinoma, Radiotherapy, surgery, prognosis, SEER database

2.

miR-6077 Promotes Cisplatin/Pemetrexed Resistance in Lung Adenocarcinoma by Targeting CDKN1A/Cell Cycle Arrest and KEAP1/Ferroptosis Pathways

Number of pages: 42 Posted: 05 Nov 2021
Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery, Fudan University - Department of Thoracic Surgery and Fudan University - Department of Thoracic Surgery
Downloads 41 (931,052)

Abstract:

Loading...

miRNA, cisplatin, pemetrexed, chemoresistance, CRISPR/Cas9, cell cycle arrest, ferroptosis, RNA-Seq, homology-directed repair, lncRNA.